US Bancorp’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.76M Buy
22,471
+1,232
+6% +$521K 0.01% 468
2026
Q1
$10.1M Buy
21,239
+15
+0.1% +$7.55K 0.01% 411
2025
Q4
$9.91M Sell
21,224
-183
-0.9% -$85K 0.01% 432
2025
Q3
$9.12M Buy
21,407
+2,543
+13% +$986K 0.01% 454
2025
Q2
$7.23M Buy
18,864
+155
+0.8% +$55.9K 0.01% 497
2025
Q1
$6.46M Buy
18,709
+495
+3% +$159K 0.01% 518
2024
Q4
$5.47M Buy
18,214
+965
+6% +$337K 0.01% 562
2024
Q3
$7.01M Buy
17,249
+658
+4% +$241K 0.01% 506
2024
Q2
$5.33M Buy
16,591
+7,464
+82% +$2.43M 0.01% 559
2024
Q1
$3.04M Buy
9,127
+570
+7% +$174K ﹤0.01% 708
2023
Q4
$2.32M Sell
8,557
-221
-3% -$54.6K ﹤0.01% 782
2023
Q3
$2.16M Sell
8,778
-960
-10% -$263K ﹤0.01% 771
2023
Q2
$2.96M Buy
9,738
+30
+0.3% +$8.34K ﹤0.01% 677
2023
Q1
$2.56M Buy
9,708
+225
+2% +$57.2K ﹤0.01% 724
2022
Q4
$2.28M Buy
9,483
+662
+8% +$148K ﹤0.01% 765
2022
Q3
$1.62M Sell
8,821
-433
-5% -$86.3K ﹤0.01% 854
2022
Q2
$1.56M Sell
9,254
-2,159
-19% -$464K ﹤0.01% 904
2022
Q1
$2.86M Buy
11,413
+831
+8% +$209K ﹤0.01% 747
2021
Q4
$2.72M Sell
10,582
-696
-6% -$170K ﹤0.01% 798
2021
Q3
$2.74M Buy
11,278
+318
+3% +$77.7K 0.01% 768
2021
Q2
$2.27M Buy
10,960
+299
+3% +$60.9K ﹤0.01% 844
2021
Q1
$2.01M Buy
10,661
+654
+7% +$115K ﹤0.01% 860
2020
Q4
$1.65M Buy
10,007
+534
+6% +$78.1K ﹤0.01% 888
2020
Q3
$1.18M Sell
9,473
-3,009
-24% -$372K ﹤0.01% 926
2020
Q2
$1.21M Sell
12,482
-3,092
-20% -$321K ﹤0.01% 884
2020
Q1
$1.4M Sell
15,574
-2,121
-12% -$275K ﹤0.01% 777
2019
Q4
$2.62M Buy
17,695
+133
+0.8% +$17.9K 0.01% 684
2019
Q3
$2.12M Sell
17,562
-598
-3% -$77.3K 0.01% 747
2019
Q2
$2.46M Sell
18,160
-1,834
-9% -$232K 0.01% 702
2019
Q1
$2.61M Sell
19,994
-3,127
-14% -$420K 0.01% 677
2018
Q4
$2.88M Buy
23,121
+232
+1% +$31.1K 0.01% 608
2018
Q3
$3.19M Buy
22,889
+1,271
+6% +$158K 0.01% 645
2018
Q2
$2.22M Buy
21,618
+1,593
+8% +$161K 0.01% 763
2018
Q1
$1.94M Buy
20,025
+158
+0.8% +$15.3K 0.01% 797
2017
Q4
$1.75M Sell
19,867
-681
-3% -$54.7K 0.01% 848
2017
Q3
$1.64M Sell
20,548
-2,451
-11% -$197K 0.01% 866
2017
Q2
$2.01M Buy
22,999
+2,260
+11% +$191K 0.01% 764
2017
Q1
$1.84M Buy
20,739
+1,196
+6% +$99.7K 0.01% 809
2016
Q4
$1.45M Buy
19,543
+2,908
+17% +$218K 0.01% 883
2016
Q3
$1.26M Buy
16,635
+3,338
+25% +$256K ﹤0.01% 913
2016
Q2
$1.02M Buy
13,297
+1,579
+13% +$125K ﹤0.01% 991
2016
Q1
$915K Sell
11,718
-1,159
-9% -$80.9K ﹤0.01% 1021
2015
Q4
$871K Sell
12,877
-9,836
-43% -$686K ﹤0.01% 1035
2015
Q3
$1.76M Buy
22,713
+109
+0.5% +$9.65K 0.01% 740
2015
Q2
$2.05M Buy
22,604
+3,870
+21% +$310K 0.01% 716
2015
Q1
$1.41M Sell
18,734
-808
-4% -$58K 0.01% 853
2014
Q4
$1.43M Buy
19,542
+4,329
+28% +$304K 0.01% 839
2014
Q3
$1.07M Sell
15,213
-2,943
-16% -$195K ﹤0.01% 960
2014
Q2
$1.02M Buy
18,156
+5,722
+46% +$302K ﹤0.01% 988
2014
Q1
$653K Sell
12,434
-9,928
-44% -$494K ﹤0.01% 1187
2013
Q4
$1.07M Buy
22,362
+2,105
+10% +$97.3K ﹤0.01% 894
2013
Q3
$866K Sell
20,257
-1,500
-7% -$58.6K ﹤0.01% 952
2013
Q2
$784K Buy
+21,757
New +$842K ﹤0.01% 950

Other funds holding HCA

US Bancorp's HCA Position: Q2 2026 in Review

US Bancorp increased its HCA Healthcare (HCA) stake by 5.8% in Q2 2026, buying an estimated $521K and bringing the position to 22,471 shares worth $8.76M. The position accounts for 0.01% of the portfolio, ranked #468.

US Bancorp first reported a position in HCA in Q2 2013 and has held it in 53 quarters since. The position peaked at $10.1M in Q1 2026. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • US Bancorp held 22,471 shares of HCA Healthcare worth $8.76M as of Q2 2026.
  • US Bancorp bought 1,232 HCA Healthcare shares in Q2 2026, an estimated $521K.
  • HCA Healthcare made up 0.01% of US Bancorp's portfolio in Q2 2026, its #468 holding.
  • US Bancorp first reported a position in HCA Healthcare in Q2 2013 and has held it in 53 quarters since.
  • US Bancorp's HCA Healthcare position peaked at $10.1M in Q1 2026.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.